Sunday, August 1, 2021

Tag: Pharmaceutical

Emerging Growth Pharmaceutical Companies

Heating Up: CLS Holdings USA (OTCQB: CLSH), Inc. Announces June Results,...

LAS VEGAS, NV / ACCESSWIRE / July 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating...

CLS Holdings USA, Inc. (OTCQB: CLSH) Achieves Substantial Year-Over-Year Results for...

LAS VEGAS, NV / ACCESSWIRE / June 15, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating...

Marble Arch Research Report Healixa, Inc. (OTC Pink: EMOR)

COMPANY SUMMARY On June 22, 2020, Emerald Organic Products Inc. (OTCPK: EMOR), a Nevada Corporation, changed its name to Healixa Inc., to reflect the company’s...

Healthcare Technology Disruptor Obtains National Reach

Look at Healixa, Inc. (OTC Pink: EMOR)

Last Mile Ride Share answer for Healixa (OTC Pink: EMOR)?

A Virtual Care Platform Covering Diagnosis to Treatment without leaving your Home The camera on your phone is more powerful than you know.  The infrared aspect...

Halberd (HALB) Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations

Halberd (HALB) Antibodies Shown To Be Effective Against Multiple Covid-19 Mutations

Can B Corp Announces Full Year 2020 Results

“As it was for many companies, 2020 was a challenging year for us,” commented Marco Alfonsi, Can B’s Chief Executive Officer. “We took the time to right-size our expenses, focus our energy on higher margin revenue opportunities and improve our positioning for future growth and profits.”

Multicorp (MCIC) Announces Change in Corporate Operations

Multicorp (MCIC) Announces Change in Corporate Operations

CLS Holdings USA, Inc. Announces Amendments to Convertible Debentures and Underlying...

 Miami, FL – March 31, 2021 (EmergingGrowth.com NewsWire) — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...

CytoDyn (OTCQB: CYDY) Stuns FDA with 400% Improvement in 14 Day...

CytoDyn Inc. (OTCMKTS: CYDY) just released stunning numbers which takes the company down one of two roads.  The first road is a quick review by the FDA...